Neonatal Screening Systems

Neonatal screening is used to detect in babies congenital diseases that are treatable only when identified during the first days of life. PerkinElmer supplies all of the products needed to establish and maintain an effective screening program.

View Technologies

Biotinidase (BTD) deficiency

Biotinidase (BTD) deficiency  View more

Congenital adrenal hyperplasia (CAH)

PerkinElmer's Neonatal17 a-OH-Progesterone (17OHP) assayfor its DELFIA®, AutoDELFIA® and GSP® platforms...  View more

Congenital Hypothyroidism

High performance, reliable CHscreening toolsThe analytical sensitivity of PerkinElmer'sNeonatal TSH...  View more

Cystic fibrosis (CF)

Top performance based onrobust DELFIA® chemistryThe Neonatal IRT assay provides highanalytical sensitivity...  View more

Galactosemia

The incidence of galactosemia is 1:14000 - 1:60000. The untreated disorder will cause poor development,...  View more

Glucose-6-phosphate dehydrogenase (G6PD) deficiency

Hemoglobinopathy

MSMS Reagents

Neonatal Biotinidase kits

Neonatal Biotinidase kits  View more

Newborn Screening Instrument Platforms

PerkinElmer platforms for dried blood spot assays include the GSP Genetic Screening Processor and the...  View more

Phenylketonuria (PKU)

Software